Supplier profile
Biocon Biologics Germany GmbH
Every public-sector award we hold for this supplier, across Germany, from 22 Aug 2024 to 2 Jul 2025.
Awards won
10
all time
Attributed value
€5
4 shared, unvalued
Buyers
4
public bodies
Active
2024–2025
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 4 | €1 |
| AOK Baden-Württemberg | 2 | not attributable |
| GWQ ServicePlus AG | 2 | €2 |
| IKK classic | 2 | €2 |
What they win
Awards
All 10 awards we hold
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Jul 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 17 Mar 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Mar 2025
- Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs - KIRSTY (Wirkstoff: Insulin aspart), ATC 10AB05 ↗DAK-Gesundheit€1awarded 23 Dec 2024
- Kirsty (Wirkstoff: Insulin aspart), ATC 10AB05 ↗DAK-Gesundheitawarded 20 Dec 2024
- Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Insulin Glargin (Semglee) ↗GWQ ServicePlus AG€1awarded 10 Dec 2024
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Biocon Biologics Germany GmbH zu Kirsty ↗IKK classic€1awarded 14 Nov 2024
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Biocon Biologics Germany GmbH zu Kirsty ↗IKK classic€1awarded 14 Nov 2024
- Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Insulin Aspart (Kirsty) ↗GWQ ServicePlus AG€1awarded 10 Nov 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 22 Aug 2024
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.